Royalty Pharma plc
NASDAQ:RPRX
25.85 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Royalty Pharma plc |
Symbool | RPRX |
Munteenheid | USD |
Prijs | 25.85 |
Beurswaarde | 11,485,206,700 |
Dividendpercentage | 2.89% |
52-weken bereik | 25.2 - 31.655 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Pablo Gerardo Legorreta |
Website | https://www.royaltypharma.com |
An error occurred while fetching data.
Over Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)